Eri Arai

7PUBLICATIONS
10CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesHaematological tumoursCancer diagnosisEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 25, 2025
Plasma cell-free DNA methylation profile before afatinib treatment is associated with progression-free and overall survival of patients with epidermal growth factor receptor gene mutation-positive non-small cell lung cancer.

Mao Fujimoto, Hiroyuki Yasuda, Eri Arai

|Oct 31, 2023
DNA methylation alterations of ADCY5, MICAL2, and PLEKHG2 during the developmental stage of cryptogenic hepatocellular carcinoma.

Satomi Makiuchi, Ying Tian, Mao Fujimoto

|Nov 08, 2022
DNA methylation status of the SPHK1 and LTB genes underlies the clinicopathological diversity of non-alcoholic steatohepatitis-related hepatocellular carcinomas.

Noboru Tsuda, Ying Tian, Mao Fujimoto

|Sep 01, 2022
Prognostication of early-onset endometrioid endometrial cancer based on genome-wide DNA methylation profiles.

Takuro Hirano, Eri Arai, Mao Fujimoto

|Feb 26, 2021
Clinicopathological impacts of DNA methylation alterations on pancreatic ductal adenocarcinoma: prediction of early recurrence based on genome-wide DNA methylation profiling.

Yutaka Endo, Mao Fujimoto, Nanako Ito

|Jul 21, 2020
Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas.

Ying Tian, Eri Arai, Satomi Makiuchi

Pageof 2

Frequent Collaborators

4 joint publications

Yae Kanai

3 joint publications

Mao Fujimoto

1 joint publications

Takuro Hirano

1 joint publications

Yuji Nakayama